• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Hilo launches wearable blood pressure monitoring tech

Hilo launches wearable blood pressure monitoring tech

July 21, 2026 By Sean Whooley

Hilo blood pressure monitoring wearable lifestyle
The Hilo Core band [Image courtesy of the company]
Hilo announced today that it launched Hilo Core, a first-of-its-kind wearable system for providing long-term blood pressure insights.

Switzerland-based Hilo, which launched out of Aktiia last year with a $42 million Series B funding round, designed Core to offer an alternative to traditional cuff-based readings. It hopes to introduce a new approach through a long-term, data-driven experience. The company said it wants to create a new category between traditional cuff-based monitors and consumer wearables.

Validated through eight clinical studies, Hilo says its technology has already been used by more than 200,000 people globally. Its U.S. rollout expands its offering to provide more comprehensive blood pressure insights in a new geography.

Core combines a lightweight wearable band, mobile app and FDA-cleared connected cuff into a unified blood pressure monitoring system. It continuously captures physiological signals to generate ambient insights.

The device uses proprietary optical technology and advanced algorithms. Calibrated and validated by periodic cuff readings, Hilo Core moves beyond point-in-time measurements to deliver long-term trend data. It captures 30-35 readings per day, the company says, including overnight insights. Then, it contextualizes them with sleep, steps and heart rate to provide a more comprehensive view of health and wellness and patterns that may signal emerging risks.

Hilo says its underlying optical blood pressure monitoring (OBPM) technology uses photoplethysmographic (PPG) signals collected at the wrist. Using this, the system estimates blood pressure without the need for frequent cuff inflation.

Hilo band with pod blood pressure monitor wearable product iamge
The Hilo Core band [Image courtesy of the company]
The launch follows a recent Series B extension, adding $19 million to the company’s coffers. That brought its total funding to more than $119 million to date.

Hilo plans to make the system available nationwide today, July 21, via Hilo.com and Amazon.

Stefan Petzinger, CEO of Hilo by Aktiia, said:

“Hilo represents a fundamental shift in how we approach blood pressure, especially in the U.S., where nearly half of adults live with hypertension, and many remain undiagnosed or undertreated. For too long, blood pressure has been measured in isolated moments, leaving critical gaps in understanding. By moving to long-term, real-world insights, we’re empowering people and their care teams to take earlier, more informed action and fundamentally change how cardiovascular health is managed. And not only does Hilo provide a more comprehensive view it also puts less daily dependency on the inflatable cuff, a technology developed in 1881 that is not exactly most convenient and comfortable in day-to-day life. ”

Filed Under: Blood Management, Business/Financial News, Featured, Health Technology, Patient Monitoring, Software / IT Tagged With: Hilo

More recent news

  • CVRx taps new CFO from Nyxoah
  • BD brings on new chief information and digital officer from Lenovo
  • Cooper Companies continues to see activist pressure to sell divisions, replace CEO
  • Cordis earns FDA nod for Selution SLR drug-eluting balloon
  • Siemens Healthineers links with Novo to advance liver fibrosis blood test

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy